|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 2:1096-1103, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

From the SAIC-Frederick Inc., Laboratory of Proteomics and Analytical Technologies, Mass Spectrometry Center, National Cancer Institute at Frederick, Frederick, MD 21702-1201
Serum potentially carries an archive of important histological information whose determination could serve to improve early disease detection. The analysis of serum, however, is analytically challenging due to the high dynamic concentration range of constituent protein/peptide species, necessitating extensive fractionation prior to mass spectrometric analyses. The low molecular weight (LMW) serum proteome is that protein/peptide fraction from which high molecular weight proteins, such as albumin, immunoglobulins, transferrin, and lipoproteins, have been removed. This LMW fraction is made up of several classes of physiologically important proteins such as cytokines, chemokines, peptide hormones, as well as proteolytic fragments of larger proteins. Centrifugal ultrafiltration of serum was used to remove the large constituent proteins resulting in the enrichment of the LMW proteins/peptides. Because albumin is known to bind and transport small molecules and peptides within the circulatory system, the centrifugal ultrafiltration was conducted under solvent conditions effecting the disruption of protein-protein interactions. The LMW serum proteome sample was digested with trypsin, fractionated by strong cation exchange chromatography, and analyzed by microcapillary reversed-phase liquid chromatography coupled on-line with electrospray ionization tandem mass spectrometry. Analysis of the tandem mass spectra resulted in the identification of over 340 human serum proteins; however, not a single peptide from serum albumin was observed. The large number of proteins identified demonstrates the efficacy of this method for the removal of large abundant proteins and the enrichment of the LMW serum proteome.
To whom correspondence should be addressed: Biomedical Proteomics Program, SAIC-Frederick Inc., National Cancer Institute at Frederick, P.O. Box B, Frederick, MD 21702-1201. Tel.: 301-846-7286; Fax: 301-846-6037; E-mail: veenstra{at}ncifcrf.gov
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Keshishian, T. Addona, M. Burgess, E. Kuhn, and S. A. Carr Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution Mol. Cell. Proteomics, December 1, 2007; 6(12): 2212 - 2229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Goldman, H. W. Ressom, M. Abdel-Hamid, L. Goldman, A. Wang, R. S. Varghese, Y. An, C. A. Loffredo, S. K. Drake, S. A. Eissa, et al. Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum Carcinogenesis, October 1, 2007; 28(10): 2149 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Belluco, E. F. Petricoin, E. Mammano, F. Facchiano, S. Ross-Rucker, D. Nitti, C. Di Maggio, C. Liu, M. Lise, L. A. Liotta, et al. Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer Ann. Surg. Oncol., September 1, 2007; 14(9): 2470 - 2476. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. J. Cho, S. J. Shan, E. J. Winsor, and E. P. Diamandis Proteomics Analysis of Human Amniotic Fluid Mol. Cell. Proteomics, August 1, 2007; 6(8): 1406 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kita, Y. Miura, J.-i. Furukawa, M. Nakano, Y. Shinohara, M. Ohno, A. Takimoto, and S.-I. Nishimura Quantitative Glycomics of Human Whole Serum Glycoproteins Based on the Standardized Protocol for Liberating N-Glycans Mol. Cell. Proteomics, August 1, 2007; 6(8): 1437 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Lopez, A. Mikulskis, S. Kuzdzal, E. Golenko, E. F. Petricoin III, L. A. Liotta, W. F. Patton, G. R. Whiteley, K. Rosenblatt, P. Gurnani, et al. A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples Clin. Chem., June 1, 2007; 53(6): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Ressom, R. S. Varghese, S. K. Drake, G. L. Hortin, M. Abdel-Hamid, C. A. Loffredo, and R. Goldman Peak selection from MALDI-TOF mass spectra using ant colony optimization Bioinformatics, March 1, 2007; 23(5): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, A. Y. Liu, P. Loriaux, B. Wollscheid, Y. Zhou, J. D. Watts, and R. Aebersold Mass Spectrometric Detection of Tissue Proteins in Plasma Mol. Cell. Proteomics, January 1, 2007; 6(1): 64 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Jacobs, L. V. DeSouza, H. Samaranayake, R. E. Pearlman, K. W. M. Siu, and L. A. Klobutcher The Tetrahymena thermophila Phagosome Proteome Eukaryot. Cell, December 1, 2006; 5(12): 1990 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu, W.-J. Qian, H. M. Mottaz, M. A. Gritsenko, A. D. Norbeck, R. J. Moore, S. O. Purvine, D. G. Camp II, and R. D. Smith Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry Mol. Cell. Proteomics, November 1, 2006; 5(11): 2167 - 2174. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu, W.-J. Qian, M. A. Gritsenko, W. Xiao, L. L. Moldawer, A. Kaushal, M. E. Monroe, S. M. Varnum, R. J. Moore, S. O. Purvine, et al. High Dynamic Range Characterization of the Trauma Patient Plasma Proteome Mol. Cell. Proteomics, October 1, 2006; 5(10): 1899 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Jaffe, D. R. Mani, K. C. Leptos, G. M. Church, M. A. Gillette, and S. A. Carr PEPPeR, a Platform for Experimental Proteomic Pattern Recognition Mol. Cell. Proteomics, October 1, 2006; 5(10): 1927 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tomosugi, H. Kawabata, R. Wakatabe, M. Higuchi, H. Yamaya, H. Umehara, and I. Ishikawa Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System Blood, August 15, 2006; 108(4): 1381 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. C. Ru, L. A. Zhu, J. Silberman, and C. D. Shriver Label-free Semiquantitative Peptide Feature Profiling of Human Breast Cancer and Breast Disease Sera via Two-dimensional Liquid Chromatography-Mass Spectrometry Mol. Cell. Proteomics, June 1, 2006; 5(6): 1095 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sheng, D. Chen, and J. E. Van Eyk Multidimensional Liquid Chromatography Separation of Intact Proteins by Chromatographic Focusing and Reversed Phase of the Human Serum Proteome: Optimization and Protein Database Mol. Cell. Proteomics, January 1, 2006; 5(1): 26 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fitter and R. James Deconvolution of a Complex Target Using DNA Aptamers J. Biol. Chem., October 7, 2005; 280(40): 34193 - 34201. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, et al. An Approach to Studying Lung Cancer-related Proteins in Human Blood Mol. Cell. Proteomics, October 1, 2005; 4(10): 1480 - 1486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lowenthal, A. I. Mehta, K. Frogale, R. W. Bandle, R. P. Araujo, B. L. Hood, T. D. Veenstra, T. P. Conrads, P. Goldsmith, D. Fishman, et al. Analysis of Albumin-Associated Peptides and Proteins from Ovarian Cancer Patients Clin. Chem., October 1, 2005; 51(10): 1933 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Banks, A. J. Stanley, D. A. Cairns, J. H. Barrett, P. Clarke, D. Thompson, and P. J. Selby Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry Clin. Chem., September 1, 2005; 51(9): 1637 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Hortin and B. Meilinger Cross-Reactivity of Amino Acids and Other Compounds in the Biuret Reaction: Interference with Urinary Peptide Measurements Clin. Chem., August 1, 2005; 51(8): 1411 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baumann, U. Ceglarek, G. M. Fiedler, J. Lembcke, A. Leichtle, and J. Thiery Standardized Approach to Proteome Profiling of Human Serum Based on Magnetic Bead Separation and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Clin. Chem., June 1, 2005; 51(6): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Molina, J. Bunkenborg, G. H. Reddy, B. Muthusamy, P. J. Scheel, and A. Pandey A Proteomic Analysis of Human Hemodialysis Fluid Mol. Cell. Proteomics, May 1, 2005; 4(5): 637 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Qian, M. E. Monroe, T. Liu, J. M. Jacobs, G. A. Anderson, Y. Shen, R. J. Moore, D. J. Anderson, R. Zhang, S. E. Calvano, et al. Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach Mol. Cell. Proteomics, May 1, 2005; 4(5): 700 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Veenstra, T. P. Conrads, B. L. Hood, A. M. Avellino, R. G. Ellenbogen, and R. S. Morrison Biomarkers: Mining the Biofluid Proteome Mol. Cell. Proteomics, April 1, 2005; 4(4): 409 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wright, D. K. Han, and R. Aebersold Mass Spectrometry-based Expression Profiling of Clinical Prostate Cancer Mol. Cell. Proteomics, April 1, 2005; 4(4): 545 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, E. C. Yi, X.-j. Li, P. Mallick, K. S. Kelly-Spratt, C. D. Masselon, D. G. Camp II, R. D. Smith, C. J. Kemp, and R. Aebersold High Throughput Quantitative Analysis of Serum Proteins Using Glycopeptide Capture and Liquid Chromatography Mass Spectrometry Mol. Cell. Proteomics, February 1, 2005; 4(2): 144 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Diamandis and D.-E. van der Merwe Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations Clin. Cancer Res., February 1, 2005; 11(3): 963 - 965. [Full Text] [PDF] |
||||
![]() |
S. K. Drake, R. A.R. Bowen, A. T. Remaley, and G. L. Hortin Potential Interferences from Blood Collection Tubes in Mass Spectrometric Analyses of Serum Polypeptides Clin. Chem., December 1, 2004; 50(12): 2398 - 2401. [Full Text] [PDF] |
||||
![]() |
B. A. Wetmore and B. A. Merrick Invited Review: Toxicoproteomics: Proteomics Applied to Toxicology and Pathology Toxicol Pathol, October 1, 2004; 32(6): 619 - 642. [Abstract] [PDF] |
||||
![]() |
N. L. Anderson, M. Polanski, R. Pieper, T. Gatlin, R. S. Tirumalai, T. P. Conrads, T. D. Veenstra, J. N. Adkins, J. G. Pounds, R. Fagan, et al. The Human Plasma Proteome: A Nonredundant List Developed by Combination of Four Separate Sources Mol. Cell. Proteomics, April 1, 2004; 3(4): 311 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Petricoin, V. Rajapaske, E. H. Herman, A. M. Arekani, S. Ross, D. Johann, A. Knapton, J. Zhang, B. A. Hitt, T. P. Conrads, et al. Toxicoproteomics: Serum Proteomic Pattern Diagnostics for Early Detection of Drug Induced Cardiac Toxicities and Cardioprotection Toxicol Pathol, January 1, 2004; 32(1_suppl): 122 - 130. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |